image

Antibiotics Market Report Scope & Overview:

The Antibiotics Market size is valued at USD 49.51 Bn in 2022 and is expected to reach USD 68.22 Bn by 2030 and grow at a CAGR of 4.09% over the forecast period of 2023-2030.

A class of medications known as antibiotics are used to treat bacterial infections. They function by eradicating bacteria or stopping their growth. Numerous bacterial infections, such as lung infections, skin infections, urinary tract infections, and some sexually transmitted diseases, can be successfully treated with antibiotics. It is crucial to remember that viral diseases like the flu and the common cold cannot be treated with antibiotics. This is due to the structural distinction between viruses and bacteria and the fact that antibiotics are designed to target only bacterial processes. The different types of antibiotics can be categorised according to their mode of action or range of activity. Penicillins, cephalosporins, macrolides, tetracyclines, and fluoroquinolones are a few examples of common antibiotic kinds. To stop the emergence of antibiotic resistance, it is essential to use antibiotics carefully. When antibiotics are overused or misused, germs can develop resistance to their effects, making infections more challenging to cure. It is crucial to take antibiotics exactly as prescribed, to the end of the recommended course, and only when absolutely required, as advised by a healthcare provider.

Antibiotics Market Revenue Analysis

Get more information on Antibiotics Market - Request Free Sample Report

Market Dynamics:

Driver :

  • The rising number of  Bacterial Infections

Most of the time, antibiotics are used to treat bacterial infections like pneumonia, skin infections, urinary tract infections, and many others. Antibiotics aid in the removal of bacteria from the body, which can cause a variety of diseases.

Restrain :

  • The side effects of antibiotics.

Antibiotic-resistant bacteria may develop as a result of antibiotic abuse and overuse. When antibiotics are administered excessively or improperly, bacteria may develop defences that allow them to thrive and spread. Because of this, infections may become more difficult to treat with medicines, increase the risk of morbidity and mortality, and be harder to control.

Opportunity :

  • The rise in drug development and R&D is related to the same.

Our knowledge of diseases and therapeutic targets has increased as a result of the quick advancements made in several scientific domains, including genomics, proteomics, and bioinformatics. High-throughput screening, computer modelling, and sophisticated imaging techniques are only a few examples of technological developments that have improved drug discovery and sped up the creation of new medicines.

Challenges :

  • Worldwide Access and Stewardship

It is still difficult to guarantee universal access to efficient antibiotics. Antibiotic accessibility, price, and appropriate use are problems for many low- and middle-income countries. Implementing antibiotic stewardship programmes to optimise antibiotic use in hospital settings can also be difficult, especially in environments with limited resources.

Impact of Russia-Ukraine War:

Ukraine's healthcare systems have been impacted by the fighting, especially in the afflicted areas. Healthcare workers have been relocated, and medical centres and hospitals were damaged or destroyed. This disruption may interfere with the efficient handling and supply of antibiotics, possibly resulting in shortages or insufficient access to these drugs.

Impact of Recession :

Economic difficulties can have an impact on the funding for new antibiotic research and development. Financial difficulties may prevent pharmaceutical firms and research organisations from making as much of an investment in antibiotic development. This may hinder the development of novel medicines and reduce the availability of potent medications to combat rising antibiotic resistance.

Market Segmentation

By Application

  • Skin Infections

  • Respiratory Infections

  • Urinary Tract Infections

  • Ear Infections

  • Others

By Drug Class

  • Penicillin

  • Macrolides

  • Tetracycline

  • Others

By Route of Administration

  • Oral

  • Parental

  • Others  

By Distribution Channel

Antibiotics Market Segmentation Analysis

Need any customization research on Antibiotics Market - Enquiry Now

Regional Analysis:

Due to a high prevalence of infectious diseases, a developed healthcare system, and active R&D efforts, the North American market for antibiotics is sizable. Since the United States has a sizable pharmaceutical industry, it plays a significant role in the development, manufacturing, and distribution of antibiotics throughout the region. Antibiotics are subject to strict rules to ensure their quality and safety, such as those set by the U.S. FDA. With its sophisticated healthcare systems, considerable R&D efforts, and keen awareness of antibiotic resistance, Europe is an important market for antibiotics. In order to combat the problem of antibiotic resistance, efforts are made to encourage responsible antibiotic usage and create antimicrobial stewardship programmes.

Key Players

The major key players are Pfizer, Abbott, Sanofi, Bayer Ag, Merck & Co, Johnson & Johnson, Astellas Pharma, GlaxoSmithKline, Novartis AG and Other Players

Bayer Ag-Company Financial Analysis

Company Landscape Analysis

Antibiotics Market Report Scope:
Report Attributes Details
Market Size in 2022  US$ 49.51 Bn
Market Size by 2030  US$ 68.22 Bn
CAGR   CAGR of 4.09% From 2023 to 2030
Base Year  2022
Forecast Period  2023-2030
Historical Data  2020-2021
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Application (Skin Infections, Respiratory Infections, Urinary Tract Infections, Ear Infections, Others)
• By Drug Class (Penicillin, Macrolides, Tetracycline, Others)
• By Route of Administration (Oral, Parental, Others)
• By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Pfizer, Abbott, Sanofi, Bayer Ag, Merck & Co, Johnson & Johnson, Astellas Pharma, GlaxoSmithKline, Novartis AG.
Key Drivers • The rising number of  Bacterial Infections
Market Opportunities • The rise in the drug development and R&D related to the same.

 

Frequently Asked Questions

Ans : The Antibiotics Market is to grow at a CAGR of 4.09%% ovewr the forecast period 2023-2030.

Ans : The major key players are Pfizer, Abbott, Sanofi, Bayer Ag, Merck & Co, Johnson & Johnson, Astellas Pharma, GlaxoSmithKline, Novartis AG.

Ans: The side effects of antibiotics.

Ans : The rising number of  Bacterial Infections

Ans: The Antibiotics Market is estimated to reach US$ 68.22 Bn by 2030.

Table of Contents

1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges

4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of the Ukraine- Russia War
4.3 Impact of Ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World

5. Value Chain Analysis

6. Porter’s 5 forces model

7. PEST Analysis

8. Antibiotics Market Segmentation, by Application
8.1 Skin Infections
8.2 Respiratory Infections
8.3 Urinary Tract Infections
8.5 Ear Infections
8.6 Others

9. Antibiotics Market Segmentation, by Drug Class
9.1 Penicillin
9.2 Macrolides
9.3 Tetracycline
9.4 Others

10. Antibiotics Market Segmentation, by Route of Administration
10.1 Oral
10.2 Parental
10.3 Others

11. Antibiotics Market Segmentation, by Distribution Channel.
11.1 Retail Pharmacy
11.2 Hospital-based Pharmacy
11.3 Online Pharmacy
11.4 Others

12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 North America Antibiotics Market by Country
12.2.2North America Antibiotics Market by Application
12.2.3 North America Antibiotics Market by Drug Class
12.2.4 North America Antibiotics Market by Route of Administration
12.2.5 North America Antibiotics Market by Distribution Channel
12.2.6 USA
12.2.6.1 USA Antibiotics Market by Application
12.2.6.2 USA Antibiotics Market by Drug Class
12.2.6.3 USA Antibiotics Market by Route of Administration
12.2.6.4 USA Antibiotics Market by Distribution Channel
12.2.7 Canada
12.2.7.1 Canada Antibiotics Market by Application
12.2.7.2 Canada Antibiotics Market by Drug Class
12.2.7.3 Canada Antibiotics Market by Route of Administration
12.2.7.4 Canada Antibiotics Market by Distribution Channel
12.2.8 Mexico
12.2.8.1 Mexico Antibiotics Market by Application
12.2.8.2 Mexico Antibiotics Market by Drug Class
12.2.8.3 Mexico Antibiotics Market by Route of Administration
12.2.8.4 Mexico Antibiotics Market by Distribution Channel
12.3 Europe
12.3.1 Europe Antibiotics Market by Country
1.3.3.2 Europe Antibiotics Market by Application
12.3.3 Europe Antibiotics Market by Drug Class
12.3.4 Europe Antibiotics Market by Route of Administration
12.3.5 Europe Antibiotics Market by Distribution Channel
12.3.6 Germany
12.3.6.1 Germany Antibiotics Market by Application
12.3.6.2 Germany Antibiotics Market by Drug Class
12.3.6.3 Germany Antibiotics Market by Route of Administration
12.3.6.4 Germany Antibiotics Market by Distribution Channel
12.3.7 UK
12.3.7.1 UK Antibiotics Market by Application
12.3.7.2 UK Antibiotics Market by Drug Class
12.3.7.3 UK Antibiotics Market by Route of Administration
12.3.7.4 UK Antibiotics Market by Distribution Channel
12.3.8 France
12.3.8.1 France Antibiotics Market by Application
12.3.8.2 France Antibiotics Market by Drug Class
12.3.8.3 France Antibiotics Market by Route of Administration
12.3.8.4 France Antibiotics Market by Distribution Channel
12.3.9 Italy
12.3.9.1 Italy Antibiotics Market by Application
12.3.9.2 Italy Antibiotics Market by Drug Class
12.3.9.3 Italy Antibiotics Market by Route of Administration
12.3.9.4 Italy Antibiotics Market by Distribution Channel
12.3.10 Spain
12.3.10.1 Spain Antibiotics Market by Application
12.3.10.2 Spain Antibiotics Market by Drug Class
12.3.10.3 Spain Antibiotics Market by Route of Administration
12.3.10.4 Spain Antibiotics Market by Distribution Channel
12.3.11 The Netherlands
12.3.11.1 Netherlands Antibiotics Market by Application
12.3.11.2 Netherlands Antibiotics Market by Drug Class
12.3.11.3 Netherlands Antibiotics Market by Route of Administration
12.3.11.4 Netherlands Antibiotics Market by Distribution Channel
12.3.12 Rest of Europe
12.3.12.1 Rest of Europe Antibiotics Market by Application
12.3.12.2 Rest of Europe Antibiotics Market by Drug Class
12.3.12.3 Rest of Europe Antibiotics Market by Route of Administration
12.3.12.4 Rest of Europe Antibiotics Market by Distribution Channel
12.4 Asia-Pacific
12.4.1 Asia Pacific Antibiotics Market by Country
12.4.2 Asia Pacific Antibiotics Market by Application
12.4.3 Asia Pacific Antibiotics Market by Drug Class
12.4.4Asia Pacific Antibiotics Market by Route of Administration
12.4.5Asia Pacific Antibiotics Market by Distribution Channel
12.4.6 Japan
12.4.6.1 Japan Antibiotics Market by Application
12.4.6.2 Japan Antibiotics Market by Drug Class
12.4.6.3 Japan Antibiotics Market by Route of Administration
12.4.6.4 Japan Antibiotics Market by Distribution Channel
12.4.7 South Korea
12.4.7.1 South Korea Antibiotics Market by Application
12.4.7.2 South Korea Antibiotics Market by Drug Class
12.4.7.3 South Korea Antibiotics Market by Route of Administration
12.4.7.4 South Korea Antibiotics Market by Distribution Channel
12.4.8 China
12.4.8.1 China Antibiotics Market by Application
12.4.8.2 China Antibiotics Market by Drug Class
12.4.8.3 China Antibiotics Market by Route of Administration
12.4.8.4 China Antibiotics Market by Distribution Channel
12.4.9 India
12.4.9.1 India Antibiotics Market by Application
12.4.9.2 India Antibiotics Market by Drug Class
12.4.9.3 India Antibiotics Market by Route of Administration
12.4.9.4 India Antibiotics Market by Distribution Channel
12.4.10 Australia
12.4.10.1 Australia Antibiotics Market by Application
12.4.10.2 Australia Antibiotics Market by Drug Class
12.4.10.3 Australia Antibiotics Market by Route of Administration
12.4.10.4 Australia Antibiotics Market by Distribution Channel
12.4.11 Rest of Asia-Pacific
12.4.11.1 APAC Antibiotics Market by Application
12.4.11.2 APAC Antibiotics Market by Drug Class
12.4.11.3 APAC Antibiotics Market by Route of Administration
12.4.11.4 APAC Antibiotics Market by Distribution Channel
12.5 The Middle East & Africa
12.5.1 The Middle East & Africa Antibiotics Market by Country
12.5.2 The Middle East & Africa Antibiotics Market by Application
12.5.3 The Middle East & Africa Antibiotics Market by Drug Class
12.5.4The Middle East & Africa Antibiotics Market by Route of Administration
12.5.5 The Middle East & Africa Antibiotics Market by Distribution Channel
12.5.6 Israel
12.5.6.1 Israel Antibiotics Market by Application
12.5.6.2 Israel Antibiotics Market by Drug Class
12.5.6.3 Israel Antibiotics Market by Route of Administration
12.5.6.4 Israel Antibiotics Market by Distribution Channel
12.5.7 UAE
12.5.7.1 UAE Antibiotics Market by Application
12.5.7.2 UAE Antibiotics Market by Drug Class
12.5.7.3 UAE Antibiotics Market by Route of Administration
12.5.7.4 UAE Antibiotics Market by Distribution Channel
12.5.8 South Africa
12.5.8.1 South Africa Antibiotics Market by Application
12.5.8.2 South Africa Antibiotics Market by Drug Class
12.5.8.3 South Africa Antibiotics Market by Route of Administration
12.5.8.4 South Africa Antibiotics Market by Distribution Channel
12.5.9 Rest of Middle East & Africa
12.5.9.1 Rest of Middle East & Asia Antibiotics Market by Application
12.5.9.2 Rest of Middle East & Asia Antibiotics Market by Drug Class
12.5.9.3 Rest of Middle East & Asia Antibiotics Market Route of Administration
12.5.9.4 Rest of Middle East & Asia Antibiotics Market by Distribution Channel
12.6 Latin America
12.6.1 Latin America Antibiotics Market by Country
12.6.2 Latin America Antibiotics Market by Application
12.6.3 Latin America Antibiotics Market by Drug Class
12.6.4 Latin America Antibiotics Market by Route of Administration
12.6.5  Latin America Antibiotics Market by Distribution Channel
12.6.6 Brazil
12.6.6.1 Brazil Antibiotics Market by Application
12.6.6.2 Brazil Africa Antibiotics Market by Drug Class
12.6.6.3 Brazil Antibiotics Market by Route of Administration
12.6.6.4 Brazil Antibiotics Market by Distribution Channel
12.6.7 Argentina
12.6.7.1 Argentina Antibiotics Market by Application
12.6.7.2 Argentina Antibiotics Market by Drug Class
12.6.7.3 Argentina Antibiotics Market by Route of Administration
12.6.7.4 Argentina Antibiotics Market by Distribution Channel
12.6.8 Rest of Latin America
12.6.8.1 Rest of Latin America Antibiotics Market by Application
12.6.8.2 Rest of Latin America Antibiotics Market by Drug Class
12.6.8.3 Rest of Latin America Antibiotics Market by Route of Administration
12.6.8.4 Rest of Latin America Antibiotics Market by Distribution Channel

13. Company Profile
13.1 Pfizer
13.1.1 Market Overview
13.1.2 Financials
13.1.3 Treatment/Services/Offerings
13.1.4 SWOT Analysis
13.1.5 The SNS View
13.2 Abbott
13.2.1 Market Overview
13.2.2 Financials
13.2.3 Treatment/Services/Offerings
13.2.4 SWOT Analysis
13.2.5 The SNS View
13.3 Sanofi
13.3.1 Market Overview
13.3.2 Financials
13.3.3 Treatment/Services/Offerings
13.3.4 SWOT Analysis
13.3.5 The SNS View
13.4 Bayer AG
13.4.1 Market Overview
13.4.2 Financials
13.4.3 Treatment/Services/Offerings
13.4.4 SWOT Analysis
13.4.5 The SNS View
13.5 Merck & Co
13.5.1 Market Overview
13.5.2 Financials
13.5.3 Treatment/Services/Offerings
13.5.4 SWOT Analysis
13.5.5 The SNS View
13.6 Johnson & Johnson
13.6.1 Market Overview
13.6.2 Financials
13.6.3 Treatment/Services/Offerings
13.6.4 SWOT Analysis
13.6.5 The SNS View
13.7 Astellas Pharma
13.7.1 Market Overview
13.7.2 Financials
13.7.3 Treatment/Services/Offerings
13.7.4 SWOT Analysis
13.7.5 The SNS View
13.8 GlaxoSmithKline
13.8.1 Market Overview
13.8.2 Financials
13.8.3 Treatment/Services/Offerings
13.8.4 SWOT Analysis
13.8.5 The SNS View
13.9 Novartis AG
13.9.1 Market Overview
13.9.2 Financials
13.9.3 Treatment/Services/Offerings
13.9.4 SWOT Analysis
13.9.5 The SNS View

14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share Analysis
14.3 Recent Developments

15. Used Cases & Best Practices

16. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

 

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone